Wearable monitor for urination in enlarged prostate
Part of Kidney & urinary clinical trials.
This study tests a smart wearable device that monitors your urination to help guide treatment for an enlarged prostate. You would wear a non-invasive device during your regular urodynamic testing to see how well it tracks bladder function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have an enlarged prostate (BPH).
- You need a special test called urodynamics to help plan your treatment.
- You are not scheduled for a procedure yet—this is before any invasive treatment like surgery.
- You can urinate at least 150 mL (about 5 ounces) without a catheter.
- You don't have a catheter, an uncontrolled bladder infection, or a pacemaker/electronic implant.
- You are willing and able to provide written consent to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new device designed to treat symptoms of an enlarged prostate (BPH), such as frequent or difficult urination. It may help improve urine flow and reduce discomfort without traditional surgery.
This study uses a new device to measure your bladder function over a full day, helping doctors better understand urinary symptoms. You might be eligible if you need a standard bladder test and do not have certain conditions like frequent infections or nerve-related bladder problems.
This study tests a new device called the Steep Pulse Therapy System that uses short electrical pulses to destroy extra prostate tissue without cutting. It is for men with moderate to severe BPH symptoms who have not had prior prostate surgery.
This trial tests a device called Optilume BPH Catheter System for men with enlarged prostate that causes bothersome urinary symptoms. It aims to see how safe and effective it is in real-world use, offering a possible treatment for blocked urine flow without surgery.
This trial tests a non-surgical, non-drug treatment that uses gentle electrical stimulation on the skin to help strengthen the muscles that control urine leakage. It's for men who still have urinary incontinence at least 6 months after their prostate cancer treatment.
This study compares two minimally invasive devices (iTind and UroLift) to treat urinary symptoms caused by an enlarged prostate. It is for men whose symptoms are bothersome enough to need treatment.
Hear when a new Benign Prostatic Hyperplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.